Concomitant Genetic Alterations With Response to Treatment and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR-Mutant Advanced Non-Small Cell Lung Cancer.
Level II
Where this comes from
- Record sourced from PubMed, PMID 29596544.
- Also identified by DOI 10.1001/jamaoncol.2018.0049 and PMC identifier 5885210.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines the association of concomitant genetics alterations with response to treatment with epidermal growth factor receptor tyrosine kinase inhibitors among patients with <i>EGFR</i>-mutant advanced non–small cell lung cancer.
Medical subject headings
- Antineoplastic Agents
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Mutation
- Protein Kinase Inhibitors